Expression of CD274 (PD-L1) and CD276 in B-cell Malignancies: A Study by Flowcytometry
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to B-cell Malignancies
Related studies linked through entity extraction aliases.
Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
- Status
- RECRUITING
- Phase
- NA
Evaluation of SYS6005 in Patients With Advanced Malignant Tumor
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib
- Status
- TERMINATED
- Phase
- N/A
Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Combination CAR-T Cell Therapy Targeting Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1